Xeris Biopharma Holdings, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $383.5M
Liabilities Breakdown FY2025
Total Liabilities: $369.8M
Asset Breakdown
Total Assets: $383.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $111.0M | 29.0% |
| Accounts Receivable | $51.1M | 13.3% |
| Inventory | $68.7M | 17.9% |
| Property, Plant & Equipment | $4.9M | 1.3% |
| Goodwill | $22.9M | 6.0% |
| Intangible Assets | $88.1M | 23.0% |
| Other Assets | $36.9M | 9.6% |
Liabilities Breakdown
Total Liabilities: $369.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 0.8% |
| Long-Term Debt | $220.3M | 59.6% |
| Other Liabilities | $146.4M | 39.6% |